The U.S. Food and Drug Administration lifted the pause and will now allow to resume vaccinations with Johnson & Johnson's single-shot COVID-19 vaccine following a thorough safety review by health regulators.
The FDA in mid-April temporarily halted the usage of the vaccine after six recipients developed a rare blood clotting disorder following the administration of more than 6.8 million doses.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com